President Trump’s proposed cuts to the Department of Housing and Urban Development would eliminate programs cities have used to fund things like Meals on Wheels.
NYS Entity Status
NYS Filing Date
APRIL 03, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2014 - GATEWAY I TP4 HOUSING DEVELOPMENT FUND COMPANY, INC.
AROUND THE WEB
- ‘I’d Be Hurt and Upset’: Cities Fear Trump’s Cuts to Urban Programs
By YAMICHE ALCINDOR - Friday Mar 17, 2017
- Trump Family Wedding Planner to Head New York’s Federal Housing Office
By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017
The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.
- Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
By Frank Vinluan - Wednesday Jun 14, 2017
The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]
- ‘I Have Stopped Taking My Notebooks and Pens to Meetings’
By LELA MOORE and JULIA SIMON - Saturday Jun 17, 2017
Our Top 10 Comments of the Week: Readers debate being interrupted at work, the shooting of a politician and the fate of American “Dreamers.”
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
By Frank Vinluan - Tuesday May 30, 2017
Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]
- Greater Minnesota Housing Fund Launches Impact Investment Fund
By firstname.lastname@example.org (Matt Sinclair) - Thursday Jun 8, 2017
A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]